Trial Profile
Safety and efficacy of ipragliflozin in Japanese patients with type 2 diabetes mellitus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Sep 2016
Price :
$35
*
At a glance
- Drugs Ipragliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 26 Sep 2016 Status changed from not stated to completed.
- 26 Sep 2016 New trial record